Cargando…

Alteration of platelet GPVI signaling in ST-elevation myocardial infarction patients demonstrated by a combination of proteomic, biochemical, and functional approaches

The platelet-specific collagen receptor glycoprotein VI (GPVI) is critical for the formation of arterial thrombosis in vivo. We analyzed GPVI-activated platelets from ST-elevation myocardial infarction (STEMI) patients and matched stable coronary artery disease (SCAD) controls in order to provide no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vélez, Paula, Ocaranza-Sánchez, Raymundo, López-Otero, Diego, Grigorian-Shamagian, Lilian, Rosa, Isaac, Guitián, Esteban, García-Acuña, José María, González-Juanatey, José Ramón, García, Ángel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5177944/ https://www.ncbi.nlm.nih.gov/pubmed/28004756 http://dx.doi.org/10.1038/srep39603

Ejemplares similares

GPVI surface expression and signalling pathway activation are increased in platelets from obese patients: Elucidating potential anti-atherothrombotic targets in obesity
por: Barrachina, María N., et al.
Publicado: (2019)

Clustering of glycoprotein VI (GPVI) dimers upon adhesion to collagen as a mechanism to regulate GPVI signaling in platelets
por: Poulter, N. S., et al.
Publicado: (2017)

mTOR regulates GPVI-mediated platelet activation
por: Wang, Longsheng, et al.
Publicado: (2021)

GPVI expression is linked to platelet size, age, and reactivity
por: Veninga, Alicia, et al.
Publicado: (2022)

Gene Targeting Implicates Cdc42 GTPase in GPVI and Non-GPVI Mediated Platelet Filopodia Formation, Secretion and Aggregation
por: Akbar, Huzoor, et al.
Publicado: (2011)

Rac Inhibition Causes Impaired GPVI Signalling in Human Platelets through GPVI Shedding and Reduction in PLCγ2 Phosphorylation
por: Neagoe, Raluca A. I., et al.
Publicado: (2022)

Human Platelet Protein Ubiquitylation and Changes following GPVI Activation
por: Unsworth, Amanda J., et al.
Publicado: (2019)

Platelet GPVI (Glycoprotein VI) and Thrombotic Complications in the Venous System
por: Perrella, Gina, et al.
Publicado: (2021)

Targeting platelet GPVI with glenzocimab: a novel mechanism for inhibition
por: Billiald, Philippe, et al.
Publicado: (2022)

Data on hyper-activation of GPVI signalling in obese patients: Towards the identification of novel antiplatelet targets in obesity
por: Barrachina, María N., et al.
Publicado: (2019)

Differential Inhibition of Human Atherosclerotic Plaque–Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies: Functional and Imaging Studies
por: Jamasbi, Janina, et al.
Publicado: (2015)

Dynamin 2 is required for GPVI signaling and platelet hemostatic function in mice
por: Eaton, Nathan, et al.
Publicado: (2020)

Procoagulant platelet sentinels prevent inflammatory bleeding through GPIIBIIIA and GPVI
por: Kaiser, Rainer, et al.
Publicado: (2022)

Luteolin inhibits GPVI-mediated platelet activation, oxidative stress, and thrombosis
por: Ye, Yujia, et al.
Publicado: (2023)

Evaluation of the effect of eltrombopag therapy on the platelet collagen receptor glycoprotein VI (GPVI) expression and soluble GPVI levels in young patients with immune thrombocytopenia
por: Tantawy, Azza Abdel Gawad, et al.
Publicado: (2022)

Fluorescent Advanced Glycation End Products and Their Soluble Receptor: The Birth of New Plasmatic Biomarkers for Risk Stratification of Acute Coronary Syndrome
por: Raposeiras-Roubín, Sergio, et al.
Publicado: (2013)

Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report
por: Raposeiras-Roubín, Sergio, et al.
Publicado: (2012)

Proteins Involved in Platelet Signaling Are Differentially Regulated in Acute Coronary Syndrome: A Proteomic Study
por: Fernández Parguiña, Andrés, et al.
Publicado: (2010)

Correction: Proteins Involved in Platelet Signaling Are Differentially Regulated in Acute Coronary Syndrome: A Proteomic Study
por: Fernández Parguiña, Andrés, et al.
Publicado: (2011)

Comparison of the GPVI inhibitors losartan and honokiol
por: Onselaer, Marie-Blanche, et al.
Publicado: (2019)

Chronic total occlusions in Artsakh: The last frontier
por: Gutiérrez-Chico, Juan Luis, et al.
Publicado: (2022)

Characterization of GPVI- or GPVI-CD39-Coated Nanoparticles and Their Impact on In Vitro Thrombus Formation
por: Nestele, Jeremy A., et al.
Publicado: (2021)

Differential roles for the adapters Gads and LAT in platelet activation by GPVI and CLEC-2
por: HUGHES, C E, et al.
Publicado: (2008)

Antiplatelet Activity of Tussilagone via Inhibition of the GPVI Downstream Signaling Pathway in Platelets
por: Zhou, Jing, et al.
Publicado: (2020)

Non-genomic effects of PPARγ ligands: inhibition of GPVI-stimulated platelet activation
por: Moraes, L A, et al.
Publicado: (2010)

The role of Nox1 and Nox2 in GPVI-dependent platelet activation and thrombus formation()
por: Walsh, T.G., et al.
Publicado: (2014)

Tetraspanin Tspan9 regulates platelet collagen receptor GPVI lateral diffusion and activation
por: Haining, Elizabeth J., et al.
Publicado: (2016)

The Proteoglycan Biglycan Modulates Platelet Adhesion and Thrombus Formation in a GPVI-Dependent Manner
por: Hoermann, Henrike, et al.
Publicado: (2021)

Anti‐GPVI nanobody blocks collagen‐ and atherosclerotic plaque–induced GPVI clustering, signaling, and thrombus formation
por: Jooss, Natalie J., et al.
Publicado: (2022)

Glaucocalyxin A Inhibits Platelet Activation and Thrombus Formation Preferentially via GPVI Signaling Pathway
por: Li, Wei, et al.
Publicado: (2013)

A novel naphthalimide derivative reduces platelet activation and thrombus formation via suppressing GPVI
por: Shih, Tzenge‐Lien, et al.
Publicado: (2021)

Coagulation Factor XIIIa and Activated Protein C Activate Platelets via GPVI and PAR1
por: De Simone, Ilaria, et al.
Publicado: (2022)

Correction: The use of the CNIC-Polypill in real-life clinical practice: opportunities and challenges in patients at very high risk of atherosclerotic cardiovascular disease – expert panel meeting report
por: Grigorian-Shamagian, Lilian, et al.
Publicado: (2023)

The use of the CNIC-Polypill in real-life clinical practice: opportunities and challenges in patients at very high risk of atherosclerotic cardiovascular disease – expert panel meeting report
por: Grigorian-Shamagian, Lilian, et al.
Publicado: (2023)

Harnessing the heart’s resistance to malignant tumors: cardiac-derived extracellular vesicles decrease fibrosarcoma growth and leukemia-related mortality in rodents
por: Grigorian-Shamagian, Lilian, et al.
Publicado: (2017)

Significant Hypo-Responsiveness to GPVI and CLEC-2 Agonists in Pre-Term and Full-Term Neonatal Platelets and following Immune Thrombocytopenia
por: Hardy, Alexander T., et al.
Publicado: (2018)

Constitutive Dimerization of Glycoprotein VI (GPVI) in Resting Platelets Is Essential for Binding to Collagen and Activation in Flowing Blood
por: Jung, Stephanie M., et al.
Publicado: (2012)

Role of Focal Adhesion Tyrosine Kinases in GPVI-Dependent Platelet Activation and Reactive Oxygen Species Formation
por: Carrim, Naadiya, et al.
Publicado: (2014)

Agitation-dependent biomechanical forces modulate GPVI receptor expression and platelet adhesion capacity during storage
por: Hosseini, Ehteramolsadat, et al.
Publicado: (2022)

Targeting GPVI as a novel antithrombotic strategy
por: Andrews, Robert K, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m6tdd16tpcug9d2k8tv33kbvcp